Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Investment Management • Life Science • Oncology |
Stages | Seed, Startup, Early Stage |
Investing | United States • Denmark • Europe |
Investment Range | €7,000,000 - €51,910,000 |
Assets Under Management | €215,000,000 |
Lundbeckfond Ventures is an evergreen life science venture fund with a clear focus on investing internationally in companies within the pharmaceutical, medical technology, life sciences, biotechnology, health care, clinical projects, and diagnostics sectors. With an expertise in equity investments, Lundbeckfond Ventures typically acts as a lead investor, and is interested in seed, startup, and early-stage companies. They have a preference for investing in firms based in the United States and Europe. Since being founded in 2009 and operating as a subsidiary of Lundbeckfonden, they have positioned themselves with considerable assets under management, amounting to $215 million. Lundbeckfond Ventures' investment approach is characterized by strategic investments, aiming to fuel innovation and progress in the life science field. Through their website, they communicate a commitment to advancing life sciences, supported by values of innovation and integrity. They place emphasis on sustainable growth and success by utilizing strategic insights, innovative partnerships, resource optimization, and impressive data indicative of major success metrics. Their website highlights their role in empowering life science innovation and features testimonials from industry professionals, such as Investment Analysts and Venture Partners, who commend their expertise and dedication. Additionally, they offer a blog with articles focused on groundbreaking life science innovations, aimed at informing and inspiring. Their minimum investment threshold is $7 million, with a maximum investment of $51.91 million.